4 Results for "

TTP 488

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "TTP 488" in MCE Product Catalog:

17
17 Cited Publications
製品番号: HY-50682
CAS 番号: 603148-36-3
別名: TTP488; PF-04494700
Target:  

Amyloid-β

研究分野:  

Neurological Disease Cancer

Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon also can cross the blood-brain barrier (BBB) .
loading...
    loading...
製品番号: HY-50682S
別名: TTP488-d9; PF-04494700-d9
Azeliragon-d9 (TTP488-d9) is the deuterium labeled Azeliragon (HY-50682). Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon also can cross the blood-brain barrier (BBB) .
loading...
    loading...
製品番号: HY-50682A
CAS 番号: 1284150-65-7
別名: TTP488 dihydrochloride; PF-04494700 dihydrochloride
Target:  

Amyloid-β

研究分野:  

Neurological Disease Cancer

Azeliragon dihydrochloride (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon dihydrochloride also can cross the blood-brain barrier (BBB) .
loading...
    loading...
製品番号: HY-50682R
CAS 番号: 603148-36-3
別名: TTP488 (Standard); PF-04494700 (Standard)
Azeliragon (Standard) is the analytical standard of Azeliragon. This product is intended for research and analytical applications. Azeliragon (TTP488) is an orally bioavailable inhibitor of the receptor for advanced glycation end products (RAGE) in development as a potential treatment to slow disease progression with mild Alzheimer’s disease (AD) . Azeliragon also can cross the blood-brain barrier (BBB) .
loading...
    loading...